Skip to main content
. 2022 Aug 8;12:961781. doi: 10.3389/fonc.2022.961781

Table 1.

Inclusion and exclusion criteria for patient enrollment.

Inclusion criteria Exclusion criteria
* Pathologically confirmed non-keratinizing undifferentiated or differentiated NPC
* Late T-stage NPC (T3-4N0-3M0, staged or restaged according to the AJCC 8th staging system)
* Patients who received induction chemotherapy followed by definitive concurrent chemoradiotherapy
* The radiotherapy modality was VMAT or tomotherapy
* The radiotherapy plan was available for review
* Patients who received treatment at our hospital from November 2016 to December 2020
* Early T-stage or metastatic NPC (T1-2N0-3M0 or T1-4N0-3M1, staged or restaged according to the AJCC 8th staging system)
* Patients who did not receive induction chemotherapy
* Patients who received palliative radiotherapy
* The radiotherapy modality was not VMAT or tomotherapy
* The radiotherapy plan was not available for review
* Patients who received treatment before November 2016

VMAT, volumetric modulated arc therapy.